Prevalence of ESBL, AmpC B- lactamases and MRSA among uropathogens and its antibiogram

EXCLI Journal

Volumn 12, Issue , 2013, Pages 81-88

  Sasirekha, B ^a  

^a JAIN UNIVERSITY   (India)

Author keywords

AmpC lactamases; Antibiotic resistance; ESBL; MRSA; UTI

Indexed keywords

AMIKACIN; AMPICILLIN; BETA LACTAMASE AMPC; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LINEZOLID; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; OXACILLIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PRISTINAMYCIN; PSEUDOMONIC ACID; RIFAMPICIN; SULTAMICILLIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DISK DIFFUSION; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION;

EID: 84873365790     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community- acquired urinary tract infections in the JNMC Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007;6:4-10.
2. Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM. Prevalence of methicillin resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh. Ind J Med Microbiol 2003;21:49-51.
3. CLSI. Performance standards for antimicrobial susceptibility tests. Twentieth informational supplemented. CLSI 2010; document M100-S20.
4. CLSI. Performance standards for antimicrobial disc susceptibility tests; Vol. 31 No. 1. CLSI 2011; document M100-S21.
5. Dalela G, Gupta S, Jain DK, Mehta P. Antibiotic resistance pattern in uropathogens at a tertiary care hospital at Jhalawar with special reference to ESBL, AmpC β-lactamases and MRSA production. J Clin Diagn Res 2012;6:645-51.
6. Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 2003;46:94-100.
7. Fish DN. Urinary tract infections. In: Kimble MAK, Young LY, Kradjan WA et al. (eds): Applied therapeutics: the clinical use of drugs. 9th ed. Philadelphia, PA: Lippincott, 2009.
8. Goldstein FW. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group. Eur J Clin Microbiol Infect Dis 2000;19:112-7.
9. Karlowsky JA, Thornsberry C, Jones ME, Sahm DF. Susceptibility of antimicrobialresistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clin Infect Dis 2003;36:183-7.
10. Karou SD, Iboudo DP, Nadembega WMC, Ameyapoh Y, Quermi D, Pignatelli S et al. Antibiotics resistane in urinary tract bacteria in Ouagadougou. Pak J Biol Sci 2009; 12:712-6.
11. Khameneh ZR, Afshar AT. Antimicrobial susceptibility pattern of urinary tract pathogens. Saudi J Kidney Dis Transpl 2009;20: 251-3.
12. Kolawole AS, Kolawole OM, Kandaki-Olukemi YT, Babatunde SK, Durowade KA, Kolawole CF. Prevalence of urinary tract infections (UTI) among patients attending DalhatuAraf Specialist Hospital, Lafia, Nasarawa State, Nigeria. Int J Medicinal Med Sci 2009;1:163-7.
13. Koneman EW, Allen SD, Janda WM, Schreckenberger PC. The Enterobacteriaceae. In: Koneman's color atlas and textbook of diagnostic microbiology, 6th ed (pp 211-302). Philadelphia, PA: Lippincott Williams & Wilkins, 2006a.
14. Koneman EW, Allen SD, Janda WM, Schreckenberger PC. The gram positive cocci. I. Staphylococci and related organisms. In: Koneman's color atlas and textbook of diagnostic microbiology, 6th ed (pp 624-62). Philadelphia, PA: Lippincott Williams & Wilkins, 2006b.
15. Manges AR, Natarajan P, Solberg OD, Dietrich PS, Riley LW. The changing prevalence of drug-resistant Escherichia coli clonal groups in a community: evidence for community outbreaks of urinary tract infections. Epidemiol Infect 2006;134:425-31.
16. Manjunath GN, Prakash R, Annam V, Shetty K. The changing trends in the spectrum of the antimicrobial drug resistance pattern of uropathogens which were isolated from hospitals and community patients with urinary tract infections in Tumkur and Bangalore. Int J Biol Med Res 2011;2:504-50.
17. Mehrgan H, Arab-Halvaii Z. High prevalence of extended-spectrum beta lactamaseproducing Klebsiella pneumoniae in a tertiary care hospital in Tehran, Iran. J Infect Dev Ctries 2010;4:132-8.
18. Mehta M, Dutta P, Gupta V. Bacterial isolates from burn wound infections and their antibiograms: A eight-year study. Indian J Plast Surg 2007;40:25-8.
19. Mohammadi M, Ghasemi E, Mokhayeri H, Pournia Y, Boroun H. Antimicrobial resistance patterns of E. coli detected from hospitalized urine culture samples. Asian J Biol Sci 2010;3:195-201.
20. Mohammed A, Mohammed S, Asad UK. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007,6:4-10.
21. Moyo SJ, Aboud S, Kasubi M, Lyamuya EF, Maselle SY. Antimicrobial resistance among producers and non- producers of extended spectrum beta lactamases in urinary isolates at a tertiary hospital in Tanzania. BMC Research Notes 2010;3:348-52.
22. Muvunyi CM, Masaisa F, Bayingana C, Mutesa L, Musemakweri A, Muhirwa G et al. Decreased susceptibility to commonly used antimicrobial agents in bacterial pathogens isolated from urinary tract infections in Rwanda: Need for new antimicrobial guidelines. Am J Trop Med Hyg 2011;84: 923-8.
23. Narayanaswamy A, Mallika M. Prevalence of extended spectrum beta lactamases in urinary isolates of Escherichia coli in a tertiary care hospital, Chennai, South India. Internet J Med 2011;6:39-43.
24. Ndugulile F, Jureen R, Harthug S, Urassa W, Langeland N. Extended spectrum β- lactamases among gram-negative bacteria of nosocomial origin from an Intensive Care Unit of a tertiary health facility in Tanzania. BMC Infect Dis 2005;5:86-91.
25. Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Contr 2006;34:20-8.
26. Rajaduraipandi K, Mani KR, Panneerselvam K, Mani M, Manikandan P. Prevalence and antimicrobial susceptibility pattern of methicillin resistant S. aureus: A multicentre study. Ind J Med Microbiol 2006;26:34-8.
27. Sasirekha B, Srividya S. Occurrence of plasmid mediated AmpC β-lactamses among Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care hospital in Bangalore. Ind J Microbiol 2012;52:174-9.
28. Singhal S, Mathur T, Khan S, Upadhyay DJ, Chugh S, Gaind R et al. Evaluation of the methods for AmpC β-lactamase in gram negative clinical isolates from tertiary care hospitals. Ind J Med Microbiol 2005;23: 120-4.
29. Smith RD, Coast J. Antimicrobial resistance: a global response. Bull World Health Organ 2002;80:126-33.
30. Steinke DT, Seaton RA, Phillips G, Mac-Donald TM, Davey PG. Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case-control study with multivariate analysis for other risk factors. J Antimicrob Chemother 2001;47:781-7.
31. Verma S, Joshi S, Chitnis V, Hemwani N, Chitnis D. Growing problem of methicillin resistant Staphylococci: Indian scenario. Ind J Med Sci 2000;54:535-40.